---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-048212"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2021-09-15T23:59:59+00:00"
generated_at: "2026-06-29T03:25:32.404984+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# China Pharma issues 1.76M shares to CEO to offset accrued compensation; grants option to director

## Summary
- Compensation Committee approved 1,760,000 shares to CEO Zhilin Li at $0.67/share to partially offset $1,666,706 in accrued unpaid cash compensation.
- Unpaid cash compensation reduced from $1,666,706 to $487,506 after share issuance.
- Director Gene Michael Bennett granted immediate-vest incentive stock option to purchase 65,000 shares at $1.47/share, expiring Sept 9, 2024.
- Options granted under 2010 Long-Term Incentive Plan; shares/options vest immediately with no restrictions.

## SEC filing metadata
- accession: 0001213900-21-048212
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2021-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390021048212/0001213900-21-048212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390021048212/ea147480-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-048212
- JSON: https://secwatch.observer/filing/0001213900-21-048212.json
- Plain text: https://secwatch.observer/filing/0001213900-21-048212.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.